Roche Multiple Sclerosis Drug Meets Main Goals in Two Late-Stage Trials

Fenebrutinib met primary goals in two late-stage trials for the treatment of two different forms of multiple sclerosis.

Roche’s Multiple Sclerosis Drug Reduced Relapses in Two Trials

Roche Holding AG said a multiple sclerosis drug showed it could work for most forms of the disease in two late-stage trials, ...

Unique immune signatures can distinguish rare autoimmune condition from multiple sclerosis

Myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD) is a rare autoimmune condition in which the body's ...

Multiple Sclerosis Explained: Symptoms, Risk Factors & How It’s Treated

Multiple sclerosis (MS) is one of the most common autoimmune diseases affecting the brain and spinal cord, with 2.9 million ...

Roche's experimental MS drug hits main goal in one of two key trials

Roche's experimental multiple sclerosis drug achieved its main goal in one of two key late-stage trials testing it against ...
STAT

Canada loses measles elimination status — as does the entire Americas region

Canada has formally lost its measles elimination status, the country’s public health agency announced, triggering the loss of ...

Country music world rocked by icon’s death. Here’s everyone we lost in 2025

The country music world has lost some iconic names in 2025. As we head into the homestretch, we take a moment to look back at the country music stars and influential names that have been lost thus far ...